Deposition of coarse particles in cystic fibrosis: Model predictions versus experimental results

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 17, Issue 3, 2004, Pages 239-248

  Brown, James S ^a,b   Bennett, William D ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Aerosol deposition; Cystic fibrosis; Ventilation distribution

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DOSIMETRY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; LUNG COMPLIANCE; LUNG RESISTANCE; LUNG VENTILATION; MALE; PARTICLE SIZE; PARTICULATE MATTER; TIDAL VOLUME;

ADMINISTRATION, INHALATION; AEROSOLS; AIRWAY RESISTANCE; CYSTIC FIBROSIS; FUNCTIONAL RESIDUAL CAPACITY; HUMANS; LUNG; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PULMONARY VENTILATION; RESPIRATORY MECHANICS; TIDAL VOLUME;

EID: 4644276293     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2004.17.239     Document Type: Article

References (43)

1. Berger, M. 2002. Lung inflammation early in cystic fibrosis. Am. J. Respir. Crit. Care Med. 165:857-858.
2. Davis, P.B., M. Drumm, and M.W. Konstan. 1996. Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154:1229-1256.
3. Ramsey, B.W., H.L. Dorkin, J.D. Eisenberg, et al. 1993. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N. Engl. J. Med. 328:1740-1746.
4. Anderson, P.O., R.H. Sicker-Walker, D.B. Strominger, et al. 1974. Pulmonary deposition of aerosol in children with cystic fibrosis. J. Pediatr. 84:479-484.
5. Laube, B.L., J.M. Links, N.D. LaFrance, et al. 1989. Homogeneity of bronchopulmonary distribution of 99mTc aerosol in normal subjects and in cystic fibrosis. Chest 95:822-830.
6. MacLusky, I., H. Levison, R. Gold, et al. 1986. Inhaled antibiotics in cystic fibrosis: Is there a therapeutic effect? J. Pediatr. 108:861-865.
7. Landau, L.I., and P.D. Phelan. 1973. The spectrum of cystic fibrosis: A study of pulmonary mechanics in 46 patients. Am. Rev. Respir. Dis. 108:593-602.
8. Bedrossian, C.W.M., S.D. Greenberg, D.B. Singer, et al. 1976. The lung in cystic fibrosis: A quantitative study including prevalence of pathologic findings among different age groups. Hum. Pathol. 7:195-204.
9. Baltimore, R.S., C.D.C. Christie, and G.J.W. Smith. 1989. Immunohistopathologic localization of pseudomonas aeruginosa in lung from patients with cystic fibrosis. Am. Rev. Respir. Dis. 140:1650-1661.
10. Tomashefski, J.F., Jr., M. Bruce, H.I. Goldberg, et al. 1986. Regional distribution of macroscopic lung disease in cystic fibrosis. Am. Rev. Respir. Dis. 133:535-540.
11. Tiddens, H.A.W.M. 2002. Detecting early structural lung damage in cystic fibrosis. Pediatr. Pulmonol. 34:228-231.
12. Santamaria, F., G. Grillo, G. Guidi, et al. 1998. Cystic fibrosis: When should high-resolution computed tomography of the chest be obtained. Pediatrics 101:908-913.
13. Cartier, Y., P.V. Kavanagh, T. Johkoh, et al. 1999. Bronchiectasis: Accuracy of high-resolution CT in the differentiation of specific diseases. AJR Am. J. Roentgenol. 173:47-52.
14. Anderson, P.O., R.H. Sicker-Walker, D.B. Strominger, et al. 1974. Quantitative assessment of regional ventilation and perfusion in children with cystic fibrosis. Radiology 111:151-155.
15. Evans, I., G. Hambleton, N. Mann, et al. 1987. The distribution of lung damage in children with cystic fibrosis and its relationship to colonization with pseudomonas aeroginosa. Eur. J. Nucl. Med. 12:620-622.
16. Brown, J.S., K.L. Zeman, and W.D. Bennett. 2001. Regional deposition of coarse particles and ventilation distribution in patients with cystic fibrosis. J. Aerosol Med. 14:443-454.
17. Maffessanti, M., M. Candusso, F. Brizzi, et al. 1996. Cystic fibrosis in children: HRCT findings and distribution of disease. J. Thorac. Imaging 11:27-38.
18. Davis, PB. 1993. Pathophysiology of the lung disease in cystic fibrosis. In Cystic Fibrosis. P.B. Davis, ed. New York: Dekker, 193-218.
19. Martonen, T., I. Katz, and W. Cress. 1995. Aerosol Deposition as a function of airway disease: Cystic fibrosis. Pharm. Res. 12:96-102.
20. Martonen, T., D. Hwang, I. Katz, et al. 1997. Cystic fibrosis: Treatment with a supercomputer drug delivery model. Adv. Eng. Software 28:359-364.
21. Anderson, P.J., J.D. Blanchard, J.D. Brain, et al. 1989. Effect of cystic fibrosis on inhaled aerosol boluses. Am. Rev. Respir. Dis. 140:1317-1324.
22. Ilowite, J., J.D. Gorvoy, and G.C. Smaldone. 1987. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am. Rev. Respir. Dis. 136:1445-1449.
23. Weibel, E.R. 1963. Morphology of the Lung. New York, Academic.
24. Mead, J., and J. Milic-Emili. 1964. Theory and methodology in respiratory mechanics with glossary of symbols. In Handbook of Physiology. Vol. 1. American Physiology Society, Washington, D.C., 363-376.
25. Otis, A.B., C.B. McKerrow, R.A. Bartlett, et al. 1956. Mechanical factors in distribution of pulmonary ventilation. J. Appl. Physiol. 8:427-443.
26. Pedley, T.J., R.C. Schroter, and M.F. Sudlow. 1970. The prediction of pressure drop and variation of resistance within the human bronchial airways. Respir. Physiol. 9:387-405.
27. DuBois, A.B., A.W. Brody, D.H. Lewis, et al. 1956. Oscillation mechanics of lungs and chest in man. J. Appl. Physiol. 8:587-594.
28. Briant, J.K. 1990. Calculation of equivalent aerosol particle mobility in different mixtures of gases used to study convective transport in airways. J. Aerosol Med. 3:221-232.
29. Ultman, J.S. 1985. Gas transport in the conduction airways. In Gas Mixing and Distribution in the Lung. L.A. Engel and M. Paiva, eds. New wYork: Dekker, 63-136.
30. Martonen, T.B., and I.M. Katz. 1993. Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters. Pharm. Res. 10:871-878.
31. Kim, C.S., and A.J. Iglesias. 1989. Deposition of inhaled particles in bifurcating airway models: I. Inspiratory deposition. J. Aerosol Med. 2:1-14.
32. Kim, C.S., A.J. Iglesias, and L. Garcia. 1989. Deposition of inhaled particles in bifurcating airway models: II. Expiratory deposition. J. Aerosol Med. 2:15-27.
33. Littel, R.C., G.A. Milliken, W.W. Stroup, et al. 1996. SAS System for Mixed Models. SAS Institute Inc., Cary, NC.
34. Pinheiro, J.C. and D.M. Bates. 2000. Mixed-Effects Models in S and S-Plus. Springer, New York.
35. Regnis, J.A., K.L. Zeman, P.G. Noone, et al. 2000. Prolonged airway retention of insoulbule particles in cystic fibrosis versus primary ciliary dyskinesia. Exp. Lung Res. 26:149-162.
36. Gurney, J.W., T.G. Habbe, and J. Hicklin. 1997. Distribution of disease in cystic fibrosis: Correlation with pulmonary function. Chest 112:357-362.
37. Meyer, K.C., A. Sharma, N.S. Rosenthal, et al. 1997. Regional variability of lung inflammation in cystic fibrosis. Am. J. Respir. Crit. Care Med. 156:1536-1540.
38. Gutierrez, J.P., K. Grimwood, D.S. Armstrong, et al. 2001. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur. Respir. J. 17:281-286.
39. Dakin, C.J., A.H. Numa, H. Wang, et al. 2002. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165:904-910.
40. Miller, F.J., S. Anjilvel, M.G. Menache, et al. 1995. Dosimetric issues relating to particle toxicity. Inhal. Toxicol. 7:615-632.
41. Kim, C.S., L.K. Brown, G.G. Lewars, et al. 1983. Deposition of aerosol particles and flow resistance in mathematical and experimental airway models. J. Appl. Physiol. 55:154-163.
42. Brown, J.S., T.R. Gerrity, and W.D. Bennett. 1998. Effect of ventilation distribution on aerosol bolus dispersion and recovery. J. Appl. Physiol. 85:2112-2117.
43. Jalowayski, A.A., S.M. Lewis, I. Young, et al. 1982. Distribution of specific ventilation in cystic fibrosis. Respiration 43:249-257.